Similares a Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results

20 vecinos (text_768) · 82 views · HCPLive · Estados Unidos


★	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	82	Estados Unidos
14	Étude CADENCE : Résultats prometteurs pour le sotatercept dans une forme rare d'HTAP	Cardio-online @cardio-online9873	2.3K	Francia	85
9	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	86
11	Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients	HCPLive @hcplivenews	683	Estados Unidos	85
2	Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026	HCPLive @hcplivenews	548	Estados Unidos	95
8	La Universitat se suma al Dia Europeu de Dèficit d'Alfa-1	Universitat de València @universitatvalencia	481	España	86
15	SGLT2 EN ERC Beneficio en todos los estadios	ENSEÑANDO MEDICINA INTERNA @carloswaldomi	383	—	85
20	TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity	HCPLive @hcplivenews	350	Estados Unidos	85
6	Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD \| ATS 2026	HCPLive @hcplivenews	301	Estados Unidos	86
19	Ralinepag Cuts PAH Clinical Worsening Risk by 55%, With Vallerie McLaughlin, MD \| ATS 2026	HCPLive @hcplivenews	290	Estados Unidos	85
16	Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes	HCPLive @hcplivenews	206	Estados Unidos	85
4	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	86
1	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	156	Estados Unidos	100
17	Best Practices for Preclinical Thoracic Aortopathy Studies	The Marfan Foundation @themarfanfoundation	130	Estados Unidos	85
5	Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes \| ATS 2026	HCPLive @hcplivenews	117	Estados Unidos	86
13	Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension	HCPLive @hcplivenews	112	Estados Unidos	85
3	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	87
7	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	86
10	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos	86
18	Continuous Ketone Monitoring May Guide SGLT2i Use in T1D	HCPLive @hcplivenews	33	Estados Unidos	85
12	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos	85